Cartesian Therapeutics In Share Price Today: Live Updates & Key Insights
Cartesian Therapeutics In share price today is $6.51, up -0.91%. The stock opened at $6.42 against the previous close of $6.57, with an intraday high of $6.7 and low of $6.4.
Cartesian Therapeutics In Share Price Chart
Cartesian Therapeutics In
Cartesian Therapeutics In Share Price Performance
Cartesian Therapeutics In Institutional Holdings
Cartesian Therapeutics In Market Status
Cartesian Therapeutics In Fundamentals
Market Cap 169.28 M
PB Ratio 31.2575
PE Ratio 0.0
Enterprise Value 38.50 M
Total Assets 296.41 M
Volume 106531
Cartesian Therapeutics In Company Financials
About Cartesian Therapeutics In & investment objective
Company Information Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Organisation Biotechnology
Employees 75
Industry Biotechnology
CEO Dr. Carsten Brunn Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Cartesian Therapeutics In FAQs
What is the share price of Cartesian Therapeutics In today?
The current share price of Cartesian Therapeutics In is $6.51.
Can I buy Cartesian Therapeutics In shares in India?
Yes, Indian investors can buy Cartesian Therapeutics In shares by opening an international trading and demat account with Motilal Oswal.
How to buy Cartesian Therapeutics In shares in India?
You can easily invest in Cartesian Therapeutics In shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Cartesian Therapeutics In shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Cartesian Therapeutics In.
Can I buy fractional shares of Cartesian Therapeutics In?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Cartesian Therapeutics In?
Cartesian Therapeutics In has a market cap of $169.28 M.
In which sector does Cartesian Therapeutics In belong?
Cartesian Therapeutics In operates in the Biotechnology sector.
What documents are required to invest in Cartesian Therapeutics In stocks?
To invest, you typically need:
What is the PE and PB ratio of Cartesian Therapeutics In?
The PE ratio of Cartesian Therapeutics In is N/A and the PB ratio is 31.26.